CEPiA (Commercial & External Partnership, Industrial Affairs) is an organization fully dedicated to third-party activities within the industrial affairs of Sanofi.
CEPiA offer a flexible or a fully integrated service, according to the project’s needs. This offer can combine:
CEPiA will continually provide technical support, quality & regulatory support and strong customer service throughout the entire process.
CEPiA Sales is a Sanofi activity dedicated to the manufacture and supply of a broad range of APIs available on a catalogue basis.
By employing its exhaustive industrial capabilities, facilities and expertise expected of large pharma, CEPiA provides its clients with ‘fast to market’ solutions.
CEPiA offers high quality pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API’s):
CEPiA offer API contract manufacturing and custom synthesis competences from small molecules to biologics, from lab scale to commercial quantities. Additionally, we offer extensive drug product facilities.
To handle complex industrial projects, CEPiA relies on the wide Sanofi Industrial network. Roughly 16 chemical and biotech sites located in six countries (mainly in Europe) manufacture intermediates and APIs for third-party projects.
Around 38 pharmaceutical sites located in 25 countries worldwide offer their production capacities for the third-party market.
In total, more than 50 Sanofi sites support CEPiA activity.
CEPiA offer customers Sanofi’s experience and expertise from Process Development to industrial scale production.
They offer custom synthesis & API Contract Manufacturing under cGMP conditions.
Experienced in Pharmaceutical Contract Manufacturing
CEPiA offer you know-how and expertise in:
Customers and Partners benefit from CEPiA’s experience, from Toll manufacturing to a full range of Services including API, at the quality standards of Sanofi.